TBG is used to reduce the number of false-positive referrals (FPRs) due to (partial) TBG deficiency which is associated with reduced total T4 concentrations in combination with normal free T4 (fT4) concentrations (2, 3). The gene discussed is CD4; the disease is hyperinsulinemic hypoglycemia, familial, 4.